DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Jerusalem G, Park YH, Yamashita T. et al.
CNS Metastases in HER2-Positive Metastatic Breast Cancer Treated With Trastuzumab Deruxtecan: DESTINY-Breast01 Subgroup Analyses. European Society for Medical Oncology (ESMO) Breast Cancer Virtual Meeting, May 2020. #1380.
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.